Trials / Completed
CompletedNCT03583489
Study of APD421 With and Without Ondansetron
A Randomised, Double-blind, Placebo-controlled, Crossover Study in Healthy Adult Subjects to Investigate the Effect of Intravenous APD421, With and Without Ondansetron, on Cardiac Conduction
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Acacia Pharma Ltd · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Collection of pharmacokinetic and electrocardiograph data from healthy volunteers given APD421 +/- ondansetron
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | APD421 | 10 mg IV |
| DRUG | Placebo | IV |
| DRUG | Ondansetron | 4 mg IV |
Timeline
- Start date
- 2018-07-17
- Primary completion
- 2018-08-13
- Completion
- 2018-08-13
- First posted
- 2018-07-11
- Last updated
- 2018-10-01
Locations
1 site across 1 country: United Kingdom
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03583489. Inclusion in this directory is not an endorsement.